Revibe is a technology company.
Revibe has raised $9.0M across 2 funding rounds.
Revibe has raised $9.0M in total across 2 funding rounds.
Revibe Technologies is a digital therapeutics company developing wearable technology to treat attention and focus challenges, primarily for ADHD and Autism, by fusing behavioral science with AI-driven smartwatches that deliver personalized vibration reminders.[1][2][6] The product serves children, students, adults, educators, clinicians, and caregivers, solving issues like distraction in classrooms and workplaces through discreet, data-tracking interventions that enhance self-regulation and provide actionable insights via an app dashboard.[2][6][7] Formerly FokusLabs, founded in 2013, it has sold over 40,000 units, collected 10 million hours of user data, and recently launched via Pearson partnership using Samsung Galaxy Watch7 hardware as of October 2025, marking strong growth momentum in the digital health space.[1][3][7]
Revibe Technologies was founded in 2013 by school psychologist Rich Brancaccio in Wake Forest, North Carolina, after observing students struggle with focus despite their potential, inspiring him to create a tech solution blending psychology and wearables.[1][2][6][7] Initially launched as an over-the-counter wearable, it gained early traction with over 40,000 units sold to parents and 10 million hours of child usage data, evolving from FokusLabs Behavioral Solutions into Software as a Medical Device (SaMD) for ADHD and neurological conditions.[1][3] Key leadership includes CEO Joseph Koziak, an entrepreneurial producer in pharmaceuticals and digital therapeutics, with pivotal moments like the 2023 Prix Galien Award nomination and 2025 Pearson acquisition/launch expanding its reach.[1][3][7]
Revibe stands out in digital therapeutics through these key features:
Revibe rides the digital therapeutics and wearable health boom, capitalizing on rising ADHD diagnoses (affecting millions) and demand for non-drug alternatives amid mental health crises post-pandemic.[1][7] Timing aligns with AI advancements in personalized medicine and partnerships like Pearson-Samsung, enabling scalable SaMD amid regulatory progress for wearables.[3][6][7] Market forces favoring it include exploding edtech/healthtech integration, data-driven insights for education, and investor interest from funds like The Launch Place and RTP Capital, influencing the ecosystem by democratizing focus tools and providing 10M+ hours of behavioral data for future neurotech R&D.[3][4]
Revibe's Pearson-backed launch positions it for explosive adoption in schools and clinics, potentially expanding to broader CNS conditions with its vast dataset fueling AI refinements.[1][3][7] Trends like AI wearables for mental health and self-regulation will propel growth, evolving its influence from niche ADHD aid to mainstream learning enhancer. As distractions intensify, Revibe could redefine accessible therapeutics, building on its founder-inspired origins to level the playing field for focus-challenged users worldwide.[2][7]
Revibe has raised $9.0M in total across 2 funding rounds.
Revibe's investors include Resonance VC.
Revibe has raised $9.0M across 2 funding rounds. Most recently, it raised $7.0M Series A in July 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2024 | $7.0M Series A | Resonance VC | |
| Jul 1, 2023 | $2.0M Seed | Resonance VC |